Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Over the past 3 months, 12 analysts have published their opinion on Exelon (NASDAQ:EXC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Here's Why Nio And Baidu Shares Are Rising

Shares of several Chinese stocks, including Nio Inc - ADR (NYSE: NIO) and Baidu Inc (NASDAQ: BIDU), are trading higher on continued volatility.

Benzinga

Earnings Preview: Ollie's Bargain Outlet

Ollie's Bargain Outlet (NASDAQ:OLLI) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that Ollie's Bargain Outlet will report an earnings per share (EPS) of $0.66.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cintas's Earnings: A Preview

Cintas (NASDAQ:CTAS) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that Cintas will report an earnings per share (EPS) of $2.43.

Benzinga

Why Are FreightCar America Shares Trading Higher Today

FreightCar America, Inc. (NASDAQ:RAIL) reported fourth-quarter revenue growth of 23.8% year-over-year to $75.02 million, beating the consensus of $67 million. The company delivered 604 railcars in Q4 versus 505 railcars prior quarter and 477 railcars in Q4 2020. The gross margin for the quarter was 8.8%, down by 31 bps. EPS was…

Benzinga

Where Qorvo Stands With Analysts

Within the last quarter, Qorvo (NASDAQ:QRVO) has observed the following analyst ratings:

Benzinga

Will Chart Analysts Notice Bad Omen on Cisco Systems's Chart

If history is any guide, there may be trouble ahead for shares of Cisco Systems (NASDAQ:CSCO). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Guaranty Bancshares's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Guaranty Bancshares (NASDAQ:GNTY).

Benzinga

Hurco Companies's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Hurco Companies (NASDAQ:HURC).

Benzinga

Cerner: Dividend Insights

Thursday marks the last chance for investors to receive the next dividend payout from Cerner (NASDAQ:CERN).

Benzinga

Thursday Is Your Last Chance To Buy Great Southern Bancorp Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Great Southern Bancorp (NASDAQ:GSBC).

Benzinga

Thursday Is Your Last Chance To Buy Independent Bank Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Independent Bank (NASDAQ:INDB).

Benzinga

5 Value Stocks To Watch In The Consumer Cyclical Sector

What is a Value Stock?

Benzinga

Innate Pharma FY 2021 Earnings Conference Call On March 24, 2022 At 09:00 AM ET

Innate Pharma (NASDAQ:IPHA) will host a conference call at 09:00 AM ET on March 24, 2022, to discuss FY 2021 earnings results.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

$100 Invested In Enterprise Finl Servs 10 Years Ago Would Be Worth This Much

Enterprise Finl Servs (NASDAQ:EFSC) has outperformed the market over the past 10 years by 2.94% on an annualized basis producing an average annual return of 15.18%. Currently, Enterprise Finl Servs has a market capitalization of $1.87 billion.

Benzinga

What Are Whales Doing With JD.com

Someone with a lot of money to spend has taken a bullish stance on JD.com (NASDAQ:JD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

InterCure And Clever Leaves Enter Into International Strategic Partnership

InterCure Ltd.

Benzinga

Cue Health Offers COVID-19 Tests At Albertsons Pharmacies

Cue Health Inc (NASDAQ:HLTH) has partnered with Albertsons Companies Inc (NYSE:ACI) for COVID-19 test kits. The partnership will provide Cue’s molecular COVID-19 tests at participating Albertsons pharmacies across the country. Customers will get their test results delivered to their email in 20 minutes. The companies piloted this in-pharmacy COVID-19 testing program last fall in 40…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mid-Morning Market Update: Markets Open Higher; Nasdaq Surges Over 1%

U.S. stocks opened on a strong note this morning, with the Nasdaq Composite adding more than 1% on Tuesday.

Benzinga

Here's How Much You Would Have Made Owning Steel Dynamics Stock In The Last 20 Years

Steel Dynamics (NASDAQ:STLD) has outperformed the market over the past 20 years by 9.3% on an annualized basis producing an average annual return of 16.34%. Currently, Steel Dynamics has a market capitalization of $16.47 billion.

Benzinga

What Are Whales Doing With Qualcomm

A whale with a lot of money to spend has taken a noticeably bearish stance on Qualcomm. Looking at options history for Qualcomm (NASDAQ:QCOM) we detected 12 strange trades.

Benzinga

Microsoft Whale Trades For March 22

Someone with a lot of money to spend has taken a bearish stance on Microsoft (NASDAQ:MSFT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Upgrades

Benzinga

How Is The Market Feeling About Palisade Bio Inc. - Common Stock?

Palisade Bio Inc. - Common Stock's (NASDAQ:PALI) short percent of float has fallen 34.64% since its last report. The company recently reported that it has 116.60 thousand shares sold short, which is 1.0% of all regular shares that are available for trading.

Benzinga

Caribou Biosciences Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Caribou Biosciences (NASDAQ:CRBU) posted sales of $2.56 million. Earnings were up 11.9%, but Caribou Biosciences still reported an overall loss of $18.48 million.

1 … 847 848 849 850

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.